[Latin Name] Silybum marianum G.

[Plant Source] The dried seed of Silybum marianum G.

[Specifications]  Silymarin 80% UV & Silybin+Isosilybin 30% HPLC

[Appearance] Light Yellow Powder

[Particle size] 80 Mesh

[Loss on drying] £ 5.0%

[Heavy Metal] £10PPM

[Extract solvents] Ethanol

[Microbe]  Total Aerobic Plate Count:  £1000CFU/G

                   Yeast & Mold:  £100 CFU/G

[Storage] Store in cool & dry area, keep away from the direct light and heat.

[Shelf life]24 Months

[Package] Packed in paper-drums and two plastic-bags inside. Net weight:25kgs/drum

[What is Milk Thistle]

Milk Thistle is a unique herb which contains a natural compound called silymarin. Silymarin nourishes the liver like no other nutrient currently known. The liver acts as the body’s filter constantly cleansing to protect you from toxins.

Over time, these toxins can accumulate in the liver. Milk Thistle’s potent antioxidant properties and rejuvenating actions help keep the liver strong & healthy.

[Function]
1, Toxicology tests showed that:a strong effcets of protecting cell membrane of liver, in Clinical application, Milk Thistle

Extract has good results for the treatment of acute and chronic hepatitis, liver cirrhosis and a variety of toxic liver damage, etc.;
2, Milk Thistle Extract significantly improves the liver function of the patients with symptoms of hepatitis;

3,Clinical applications: for the treatment of acute and chronic hepatitis, cirrhosis, liver poisoning and other diseases.

TEDx Del Mar Oct 2011 Richard Insel, M.D.: Is There a Vaccine?

Our theme for TEDxDelMar 2011 was “A Search For A Cure”. In this talk, Dr. Richard Insel gives us his presentation entitled “Is There a Vaccine?”

Richard Insel, M.D. is Chief Scientific Officer for the Juvenile Diabetes Research Foundation (JDRF). Dr. Insel oversees the research strategy at the JDRF, the worlds’ largest funder of type 1 diabetes research and that is focused on curing, treating, and preventing type 1 diabetes and its complications. Prior to joining JDRF in 2003, Dr. Insel was founding Director of the Center for Human Genetics and Molecular Pediatric Disease and Professor of Pediatrics and Microbiology/ Immunology at the University of Rochester Medical Center. During his 26-year affiliation with the University of Rochester Medical Center, he also held several positions including Acting Chair of Pediatrics, Director of the Strong Children’s Research Center, and Chief of the Division of Pediatric Immunology, Allergy, and Rheumatology. His research program at the University focused on immune responses to bacterial vaccines, including polysaccharide and protein-polysaccharide conjugate vaccines, and B cell immunity. Dr. Insel was a scientific co-founder and served as a member of the Board of Directors of Praxis Biologics, a biotechnology company that developed Haemophilus influenzae conjugate vaccines, which have been instrumental in eliminating invasive disease from that pathogen in the United States. He served recently on the National Advisory Allergy and Infectious Diseases Council of the National Institutes of Health and the External Advisory Panel for the California Institute of Regenerative Medicine, and currently serves on the Board of the Alliance for Regenerative Medicine and the Steering Committee of TrialNet. Dr. Insel received pediatric and immunology training at Boston Children’s Hospital, Harvard Medical School, St. Mary’s Medical College, and the Center for Disease Control and is certified by the American Board of Pediatrics and the American Board of Allergy and Immunology.

In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TEDx event, TEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x = independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized.